S-100 Serum Levels after Minor and Major Head Injury
- 1 October 1998
- journal article
- research article
- Published by Wolters Kluwer Health in The Journal of Trauma: Injury, Infection, and Critical Care
- Vol. 45 (4) , 765-767
- https://doi.org/10.1097/00005373-199810000-00025
Abstract
S-100, a protein of astroglial cells, is described as a marker for central nervous system damage. The aim of this study was to evaluate whether the marker could give information about the severity and possibility of functional recovery after minor and severe head injury. Thirty patients after severe head injury (Glasgow Coma Scale score 12) were included. In each case, blood samples were drawn within 6 hours after injury. Outcome was estimated at hospital discharge using the Glasgow Outcome Scale. All patients who sustained minor head injury had reached a favorable outcome by the time they were discharged from the hospital. Their mean S-100 serum level was 0.35 [micro sign]g/L. Patients who sustained severe head injury and were classified as having an unfavorable outcome (31%) showed a mean serum concentration of 4.9 [micro sign]g/L, whereas patients classified as having a favorable outcome (69%) had a mean S-100 level of 1.2 [micro sign]g/L. All groups differed significantly (p < 0.05) S-100 appears to be a promising marker for the severity of head injury and neuronal damage.Keywords
This publication has 16 references indexed in Scilit:
- Comparison of serial S-100 and NSE serum measurements after severe head injuryActa Neurochirurgica, 1997
- Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injurySurgical Neurology, 1995
- Neuron-Specific Enolase in Gerbil Brain and Serum After Transient Cerebral IschemiaStroke, 1995
- Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemiaBrain Research, 1993
- Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damageActa Neurochirurgica, 1992
- Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarctionEuropean Journal of Clinical Investigation, 1991
- S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damageJournal of Neurosurgery, 1989
- Cerebrospinal fluid enolase in stroke.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- MEASUREMENT OF NEURON‐SPECIFIC (NSE) AND NON‐NEURONAL (NNE) ISOENZYMES OF ENOLASE IN RAT, MONKEY AND HUMAN NERVOUS TISSUEJournal of Neurochemistry, 1979
- ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESSThe Lancet, 1974